Aravis Pharmaceuticals Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Aravis Pharmaceuticals Pharmaceutical Export Portfolio Dataset — 2 Products, $530.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aravis Pharmaceuticals — Pharmaceutical Exporter Profile (2026) | 2 Products, $530.9K Trade | TransData Nexus

Aravis Pharmaceuticals

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $530.9K Total Trade · DGFT Verified

Aravis Pharmaceuticals is an Indian pharmaceutical exporter with a total trade value of $530.9K across 2 products in 1 therapeutic categories. Based on 16 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ranitidine ($300.0K), Bisacodyl ($230.9K), .

Aravis Pharmaceuticals — Export Portfolio & Destination Treemap

Aravis Pharmaceuticals pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Aravis Pharmaceuticals? — Company Overview & Market Position

Aravis Pharmaceuticals is an Indian pharmaceutical company established in 1987, initially operating as a wholesaler. Over the years, it has evolved into a merchant exporter and wholesale supplier of a diverse range of pharmaceutical products, including tablets, injections, capsules, syrups, surgical products, herbal medications, antibiotics, and multivitamins. The company is headquartered in Delhi, India, at 31, Sri Nagar Colony, Near Gurudwara, Village Sidhora Kalan, Delhi 110052. In June 2022, Aravis Pharmaceuticals Private Limited was incorporated with a Corporate Identification Number (CIN) of U24110DL2022PTC400381. The authorized capital is ₹1.5 million, with a paid-up capital of ₹0.1 million. The company is privately held, with a shareholding pattern indicating that promoters hold 92.83%, the public holds 4.10%, and others hold 3.07%. Aravis Pharmaceuticals has a workforce of approximately 1-10 employees. The company's website is https://aravispharmaceuticals.com/.

What Does Aravis Pharmaceuticals Export? — Product Portfolio Analysis

Top Products by Export Value

1Ranitidine$300.0K 2

Product Portfolio — Top 2 by Export Value

Aravis Pharmaceuticals exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ranitidine	Gastrointestinal	$300.0K	6	2.4%	7
2	Bisacodyl	Gastrointestinal	$230.9K	10	2.7%	9

Aravis Pharmaceuticals exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $530.9K. The top category is Gastrointestinal (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Aravis Pharmaceuticals — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Aravis Pharmaceuticals operates manufacturing facilities that produce a wide array of pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company emphasizes quality and innovation in its manufacturing processes, ensuring that its products meet international standards. While specific details about the locations and capacities of these facilities are not publicly disclosed, Aravis Pharmaceuticals has established a reputation for delivering high-quality pharmaceutical solutions.

3Key Leadership

Aravis Pharmaceuticals Private Limited is led by Directors Ravinder Kaur and Angad Singh Malhotra, both appointed on June 21, 2022. Specific details about other key executives, such as the CEO, CFO, and their roles, are not publicly available. The company's leadership is committed to driving innovation and maintaining high standards in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Aravis Pharmaceuticals Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Aravis Pharmaceuticals has a presence in various international markets, including Myanmar, Tajikistan, and Georgia. The company has exported 1,487 shipments to 48 verified buyers across these regions. Specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly disclosed. The company's focus on quality and compliance suggests adherence to international regulatory standards, but detailed information is limited.

2Emerging Markets

Aravis Pharmaceuticals has expanded its reach to emerging markets, including countries in Africa, Latin America, and Southeast Asia. The company has established manufacturing partnerships in several African countries such as Tanzania, Ghana, Kenya, Nigeria, and more, as well as in South Asian countries including Malaysia and the Philippines. These partnerships have enabled Aravis Pharmaceuticals to offer its products in these regions, contributing to improved healthcare access. While the company has not publicly disclosed WHO prequalification status, its global partnerships indicate a commitment to meeting international quality standards.

3Geographic Strategy

Aravis Pharmaceuticals — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Aravis Pharmaceuticals' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's focus on quality and international partnerships suggests adherence to global regulatory standards, but detailed information about FDA approvals and inspections is limited.

2WHO & EU GMP

Aravis Pharmaceuticals has established manufacturing partnerships with facilities that have earned multiple global certifications and accreditations, including WHO Good Manufacturing Practice (GMP), WHO current Good Manufacturing Practice (cGMP), ISO, FSSAI, Good Laboratory Practice (GLP), and NAFDAC in several countries. These certifications indicate compliance with international quality standards, enhancing the company's credibility in global markets.

3CDSCO & Indian Regulatory

Aravis Pharmaceuticals holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company has also obtained approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating its export activities. Specific details about these licenses and approvals are not publicly disclosed. The company's adherence to CDSCO regulations underscores its commitment to maintaining high standards in pharmaceutical manufacturing.

Aravis Pharmaceuticals — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Aravis Pharmaceuticals operates in a competitive landscape with numerous pharmaceutical companies offering similar products. While specific market share data is not publicly available, the company's focus on quality, innovation, and global partnerships positions it as a competitive player in the pharmaceutical export sector. The company's diverse product portfolio and international reach contribute to its competitive standing.

2Key Differentiators

Aravis Pharmaceuticals differentiates itself through its commitment to quality and innovation in pharmaceutical manufacturing. The company's extensive research and development efforts have led to the production of a wide range of pharmaceutical formulations, including antibiotics, NSAIDs, multivitamins, herbal medications, and cardiovascular drugs. Additionally, its global partnerships and adherence to international quality standards, such as WHO GMP and ISO certifications, enhance its competitive advantage.

3Strategic Position

Aravis Pharmaceuticals' current strategic direction focuses on expanding its global presence through partnerships and exports, particularly in emerging markets. The company's mission to be listed among the top 5 exporters of pharmaceutical drugs from India by 2030 reflects its ambitious growth objectives. While specific details about future strategic initiatives are not publicly disclosed, the company's emphasis on quality, innovation, and global partnerships suggests a continued focus on these areas.

Buyer Due Diligence Brief — Evaluating Aravis Pharmaceuticals as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Aravis Pharmaceuticals has a track record of exporting pharmaceutical products to various international markets, including Myanmar, Tajikistan, and Georgia. The company has exported 1,487 shipments to 48 verified buyers across these regions. This consistent export activity indicates reliability and a commitment to meeting international demand. The company's adherence to international quality standards, as evidenced by its global certifications, further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Aravis Pharmaceuticals as a supplier:

WHO GMP Certification: Ensures compliance with World Health Organization Good Manufacturing Practice standards.

ISO Certification: Demonstrates adherence to international quality management standards.

FSSAI License: Indicates compliance with the Food Safety and Standards Authority of India regulations.

Frequently Asked Questions — Aravis Pharmaceuticals

How many pharmaceutical products does Aravis Pharmaceuticals export from India?

Aravis Pharmaceuticals exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Ranitidine ($300.0K), Bisacodyl ($230.9K). Total export value is $530.9K.

What is Aravis Pharmaceuticals's total pharmaceutical export value?

Aravis Pharmaceuticals's total pharmaceutical export value is $530.9K, based on 16 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Aravis Pharmaceuticals cover?

Aravis Pharmaceuticals exports across 1 therapeutic categories. The largest are Gastrointestinal (100.0%, 2 products).

Get Full Aravis Pharmaceuticals Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.